Literature DB >> 7305940

Binding to antithrombin of heparin fractions with different molecular weights.

A Danielsson, I Björk.   

Abstract

The interaction between bovine antithrombin, a plasma proteinase inhibitor, and heparin species of different molecular weights was studied. A commercial heparin preparation was divided by gel chromatography into a number of fractions with average molecular weights ranging from 6000 to 34700. Each of these fractions was further fractionated by affinity chromatography on matrix-bound antithrombin. In the latter procedure, those heparin fractions that had molecular weights lower than about 14000 were separated into three peaks. The material in the first of these was not adsorbed on the column, and the other two peaks corresponded to the low-affinity and high-affinity peaks described previously. In contrast, high-molecular-weight heparin samples gave only the low-affinity and high-affinity fractions. U.v. difference absorption studies showed that the non-adsorbed heparin fraction bound to antithrombin in solution with a binding constant at physiological ionic strength only slightly lower than that of low-affinity heparin. The division between the two fractions thus is arbitrary and only dependent on the conditions selected for the affinity-chromatography experiment. Stoicheiometries and binding constants for the binding of several high-affinity heparin species to antithrombin were determined by fluorescence titrations. High-affinity heparin fractions of equal elution positions in the beginning of the peaks of the affinity chromatographies, but with different molecular weights, showed stoicheiometries that were not experimentally distinguishable from 1:1 and also had no appreciable differences in binding constants. However, the anticoagulant activities, calculated on a molar basis, of these fractions increased markedly with molecular weight, a behaviour that thus cannot be explained by differences in the binding of the fractions to antithrombin. In contrast, high-affinity samples of similar molecular weights, which were eluted at increasing ionic strengths from matrix-linked antithrombin, were found to have an increasing proportion of chains with two binding sites for antithrombin and also to have progressively higher binding constants. These binding properties at least partly explain the increasing anticoagulant activities that were observed for these fractions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7305940      PMCID: PMC1162623          DOI: 10.1042/bj1930427

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  THE ROLE OF SERINE IN THE LINKAGE OF HEPARIN TO PROTEIN.

Authors:  U LINDAHL; J A CIFONELLI; B LINDAHL; L RODEN
Journal:  J Biol Chem       Date:  1965-07       Impact factor: 5.157

2.  Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.

Authors:  L O Andersson; T W Barrowcliffe; E Holmer; E A Johnson; G E Sims
Journal:  Thromb Res       Date:  1976-12       Impact factor: 3.944

3.  The separation of active and inactive forms of heparin.

Authors:  L H Lam; J E Silbert; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

4.  Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.

Authors:  M Höök; I Björk; J Hopwood; U Lindahl
Journal:  FEBS Lett       Date:  1976-07-01       Impact factor: 4.124

5.  The role of heparin in the thrombin-antithrombin III reaction.

Authors:  E H Li; J W Fenton; R D Feinman
Journal:  Arch Biochem Biophys       Date:  1976-07       Impact factor: 4.013

6.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

Review 7.  Chemistry of the hemostatic mechanism and its relationship to the action of heparin.

Authors:  R D Rosenberg
Journal:  Fed Proc       Date:  1977-01

8.  Studies of glutamate dehydrogenase. The binding of NADH and NADPH to beef-liver glutamate dehydrogenase.

Authors:  J Krause; M Bühner; H Sund
Journal:  Eur J Biochem       Date:  1974-02-01

9.  Physicochemical studies of fractionated bovine heparin. I. Some dilute solution properties.

Authors:  S E Lasker; S S Stivala
Journal:  Arch Biochem Biophys       Date:  1966-08       Impact factor: 4.013

10.  Acceleration of the reaction between thrombin and antithrombin III by non-stoichiometric amounts of heparin.

Authors:  I Björk; B Nordenman
Journal:  Eur J Biochem       Date:  1976-09-15
View more
  9 in total

1.  Molecular weight and concentration of heparin in hyaluronic acid-based matrices modulates growth factor retention kinetics and stem cell fate.

Authors:  Amit K Jha; Anurag Mathur; Felicia L Svedlund; Jianqin Ye; Yerem Yeghiazarians; Kevin E Healy
Journal:  J Control Release       Date:  2015-04-27       Impact factor: 9.776

2.  Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

Review 3.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

4.  Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach.

Authors:  M K Lee; A D Lander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

5.  Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II.

Authors:  R E Hurst; M C Poon; M J Griffith
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

6.  Mechanism of inactivation of trypsin by antithrombin.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1982-10-01       Impact factor: 3.857

7.  The acceleration of the inhibition of platelet prothrombinase complex by heparin.

Authors:  V Ellis; M F Scully; V V Kakkar
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

8.  Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide.

Authors:  N Razi; E Feyzi; I Björk; A Naggi; B Casu; U Lindahl
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

9.  The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.

Authors:  M F Scully; V V Kakkar
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.